Summary
The primary objective of the Reassessment of Antiplatelet Therapy using an Individualized Strategy Based on Genetic Evaluation [RAPID GENE; NCT01184300] study was to evaluate the feasibility and test characteristics of a nurse-operated POC genetic test to determine CYP2C19*2 carrier status.
- Cardiology Clinical Trials
- Coronary Artery Disease
- Cardiology Genomics
- Nursing
- © 2011 MD Conference Express